Literature DB >> 10976412

Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction.

G E Fiszbajn1, R G Lipowicz, L Elberger, A Grabia, S D Papier, S P Brugo Olmedo, C F Chillik.   

Abstract

PURPOSE: To compare the efficiency of transvaginal ultrasound-guided functional ovarian cyst aspiration, with conservative management, in the outcome of patients undergoing assisted reproductive technique (ART) (in vitro fertilization or intracytoplasmic sperm injection). These cysts were identified before ovarian stimulation begun and after administration of a midluteal GnRH agonist.
METHODS: Fifty nine patients undergoing ART from January 1, 1997 to February 28, 1999, who developed functional ovarian cysts were included. Aspirations of these cysts (n = 14) versus conservative management (observation) (n = 45) were compared. Total number of ovarian follicles developed, number of oocytes retrieved, estradiol levels on the day of human chorionic gonadotropin, fertilization rate, number of good quality embryos transferred, implantation, and clinical pregnancy rate per cycle were evaluated.
RESULTS: No statistical differences were observed between the two groups in any of the selected parameters.
CONCLUSIONS: Cyst aspiration and conservative management showed similar implantation and pregnancy rates, in patients who develop functional ovarian cysts after pituitary down-regulation following luteal phase gonadotropin-releasing hormone agonist administration. Prospective studies are needed to confirm this trend.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10976412      PMCID: PMC3455200          DOI: 10.1023/a:1009406315729

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  12 in total

1.  Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome.

Authors:  M D Keltz; E E Jones; A J Duleba; T Polcz; K Kennedy; D L Olive
Journal:  Fertil Steril       Date:  1995-09       Impact factor: 7.329

2.  Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins.

Authors:  R N Porter; W Smith; I L Craft; N A Abdulwahid; H S Jacobs
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

3.  Ovarian cyst formation during the use of a GnRH analogue in an IVF programme.

Authors:  C T Waegemaekers; A van de Berg; A Blankhart; F M Helmerhorst; N Naaktgeboren
Journal:  Acta Eur Fertil       Date:  1987 Nov-Dec

4.  Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression.

Authors:  D R Meldrum; A Wisot; F Hamilton; A L Gutlay; D Huynh; W Kempton
Journal:  Fertil Steril       Date:  1988-09       Impact factor: 7.329

5.  Ovarian cyst aspiration and the outcome of in vitro fertilization.

Authors:  B Rizk; S L Tan; C Kingsland; C Steer; B A Mason; S Campbell
Journal:  Fertil Steril       Date:  1990-10       Impact factor: 7.329

6.  Persistent elevation of serum oestradiol levels by functional ovarian cysts despite effective pituitary desensitization with GnRH agonists.

Authors:  J M Jenkins; F W Anthony; A Lee; G M Masson; E Thomas
Journal:  Clin Endocrinol (Oxf)       Date:  1994-03       Impact factor: 3.478

7.  The development of functional ovarian cysts during pituitary down-regulation.

Authors:  J M Jenkins; F W Anthony; P Wood; D Rushen; G M Masson; E Thomas
Journal:  Hum Reprod       Date:  1993-10       Impact factor: 6.918

8.  The detrimental influence of functional ovarian cysts during in-vitro fertilization cycles.

Authors:  J M Jenkins; D W Davies; F Anthony; P Wood; S G Gadd; R H Watson; G M Masson
Journal:  Hum Reprod       Date:  1992-07       Impact factor: 6.918

9.  Follicle cyst formation following long-acting gonadotropin-releasing hormone analog administration.

Authors:  R Ron-El; A Herman; A Golan; A Raziel; Y Soffer; E Caspi
Journal:  Fertil Steril       Date:  1989-12       Impact factor: 7.329

10.  Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy.

Authors:  D Feldberg; J Ashkenazi; D Dicker; A Yeshaya; G A Goldman; D Dicker; J A Goldman
Journal:  Fertil Steril       Date:  1989-01       Impact factor: 7.329

View more
  3 in total

1.  Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist.

Authors:  Hui Ji; Yan Su; Mianqiu Zhang; Xin Li; Xiuling Li; Hui Ding; Li Dong; Shanren Cao; Chun Zhao; Junqiang Zhang; Rong Shen; Xiufeng Ling
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-29       Impact factor: 6.055

2.  Ovarian Cyst Formation Following Gonadotropin-Releasing Hormone-Agonist Administration Decreases the Oocyte Quality in IVF Cycles.

Authors:  Ozlem Gün Eryılmaz; Esma Sarıkaya; Fatma Nur Aksakal; Sevtap Hamdemir; Muammer Doǧan; Leyla Mollamahmutoǧlu
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

Review 3.  Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility.

Authors:  Rose McDonnell; Jane Marjoribanks; Roger J Hart
Journal:  Cochrane Database Syst Rev       Date:  2014-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.